Back to search

Ireland· IE-PA-PA1824/002/003

Produodopa 240 mg/ml + 12 mg/ml solution for infusion

A dopa and dopa derivatives product containing foslevodopa + foscarbidopa, registered in Ireland by AbbVie Limited. The same ATC class is registered in 3 of our 19 countries.

ATC N04BA

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedProduodopa 240 mg/ml + 12 mg/ml solut…ATCN04BAREGISTER NO.IE-PA-PA1824/002/003PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Foslevodopa + foscarbidopa is registered in 3 of 19 countries.

Countries holding a registration under ATC N04BA (dopa and dopa derivatives), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 2 of them publish a price we can compare per daily dose

Foslevodopa + foscarbidopa · ATC N04BA

3 / 19 countries

  • Ireland
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Foslevodopa + Foscarbidopa
Manufacturer
AbbVie Limited
Country
Ireland (IE)
ATC code
N04BA
ATC class
Dopa and dopa derivatives
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1824/002/003

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Foslevodopa + foscarbidopa in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All foslevodopa + foscarbidopa products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Produodopa
  • Belgium · Produodopa
  • Bulgaria · Продуодопа
  • Cyprus · Produodopa
  • Czechia · Duodopa Sc
  • Germany · Produodopa®
  • Denmark · Duodopa
  • Estonia · Produodopa
  • Spain · Duodopa
  • Finland · Produodopa
  • France · Scyova
  • Greece · Produodopa
  • Croatia · Produodopa
  • Hungary · Produodopa
  • Iceland · Produodopa
  • Italy · Duodopa
  • Liechtenstein · Produodopa
  • Lithuania · Duodopa
  • Luxembourg · Produodopa
  • Netherlands · Duodopa
  • Norway · Produodopa
  • Poland · Produodopa
  • Portugal · Duodopa
  • Romania · Produodopa
  • Sweden · Produodopa
  • Slovenia · Produodopa
  • Slovakia · Duodopa Sc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7700ca0f-071a-4d5d-81a4-8791440e0461
GET /v1/drugs/7700ca0f-071a-4d5d-81a4-8791440e0461?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "N04BA"
  ],
  "strength": null,
  "pa_number": "PA1824/002/003",
  "substances": [
    "Foslevodopa",
    "Foscarbidopa"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "23/09/2022",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about foslevodopa + foscarbidopa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.